Home Cart Sign in  
Chemical Structure| 13417-49-7 Chemical Structure| 13417-49-7

Structure of 13417-49-7

Chemical Structure| 13417-49-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 13417-49-7 ]

CAS No. :13417-49-7
Formula : C6H8O2
M.W : 112.13
SMILES Code : O=CC1=CCCOC1
MDL No. :MFCD08146636
InChI Key :RKXCKEHBMLDWET-UHFFFAOYSA-N
Pubchem ID :83423

Safety of [ 13417-49-7 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H319
Precautionary Statements:P305+P351+P338

Computational Chemistry of [ 13417-49-7 ] Show Less

Physicochemical Properties

Num. heavy atoms 8
Num. arom. heavy atoms 0
Fraction Csp3 0.5
Num. rotatable bonds 1
Num. H-bond acceptors 2.0
Num. H-bond donors 0.0
Molar Refractivity 29.65
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

26.3 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.43
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

-0.05
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

0.53
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

-0.04
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

1.57
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.69

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-0.44
Solubility 40.9 mg/ml ; 0.365 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-0.05
Solubility 99.6 mg/ml ; 0.888 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-0.65
Solubility 25.2 mg/ml ; 0.225 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-7.02 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

1.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.63

Application In Synthesis of [ 13417-49-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 13417-49-7 ]

[ 13417-49-7 ] Synthesis Path-Downstream   1~35

  • 2
  • [ 13417-49-7 ]
  • [ 4312-99-6 ]
  • [ 77342-60-0 ]
  • 3
  • [ 13417-49-7 ]
  • [ 52-51-7 ]
  • [ 133609-60-6 ]
  • 4
  • [ 13417-49-7 ]
  • [ 1629-58-9 ]
  • [ 77342-59-7 ]
  • 5
  • [ 13417-49-7 ]
  • [ 77-49-6 ]
  • [ 133632-26-5 ]
  • 6
  • [ 13417-49-7 ]
  • [ 24415-26-7 ]
  • [ 77342-61-1 ]
  • 7
  • [ 13417-49-7 ]
  • [ 16666-80-1 ]
  • [ 97847-43-3 ]
  • 8
  • [ 13417-49-7 ]
  • [ 13148-05-5 ]
  • [ 84254-73-9 ]
  • 9
  • [ 13417-49-7 ]
  • [ 108-91-8 ]
  • [ 133609-61-7 ]
  • 10
  • [ 13417-49-7 ]
  • [ 78-94-4 ]
  • [ 77342-58-6 ]
  • 11
  • [ 13417-49-7 ]
  • [ 62-53-3 ]
  • [ 86130-00-9 ]
  • 12
  • [ 13417-49-7 ]
  • [ 768-03-6 ]
  • [ 77342-62-2 ]
  • 13
  • [ 13417-49-7 ]
  • [ 80922-49-2 ]
  • 14
  • [ 13417-49-7 ]
  • [ 29687-18-1 ]
  • 15
  • [ 13417-49-7 ]
  • [ 86129-89-7 ]
  • 20
  • [ 13417-49-7 ]
  • [ 133609-62-8 ]
  • 21
  • [ 13417-49-7 ]
  • [ 133609-64-0 ]
  • 22
  • [ 13417-49-7 ]
  • [ 133609-63-9 ]
  • 23
  • [ 13417-49-7 ]
  • [ 133609-65-1 ]
  • 24
  • [ 13417-49-7 ]
  • [ 133609-73-1 ]
  • 25
  • [ 13417-49-7 ]
  • [ 133609-72-0 ]
  • 26
  • [ 13417-49-7 ]
  • [ 133609-74-2 ]
  • 27
  • [ 13417-49-7 ]
  • [ 133609-79-7 ]
  • 28
  • [ 13417-49-7 ]
  • [ 133609-70-8 ]
  • 29
  • [ 13417-49-7 ]
  • [ 133609-75-3 ]
  • 30
  • [ 13417-49-7 ]
  • [ 133609-68-4 ]
  • 31
  • [ 13417-49-7 ]
  • [ 133609-71-9 ]
  • 32
  • [ 13417-49-7 ]
  • [ 133609-66-2 ]
  • 33
  • [ 13417-49-7 ]
  • [ 133609-76-4 ]
  • 34
  • [ 13417-49-7 ]
  • [ 133609-78-6 ]
  • 35
  • [ 13417-49-7 ]
  • [ 133609-69-5 ]
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 13417-49-7 ]

Aldehydes

Chemical Structure| 6287-86-1

A100912 [6287-86-1]

Ethyl 4-formylbenzoate

Similarity: 0.68

Chemical Structure| 52178-50-4

A242705 [52178-50-4]

Methyl 3-formylbenzoate

Similarity: 0.68

Chemical Structure| 1571-08-0

A563203 [1571-08-0]

Methyl 4-formylbenzoate

Similarity: 0.68

Chemical Structure| 60656-87-3

A261490 [60656-87-3]

2-(Benzyloxy)acetaldehyde

Similarity: 0.67

Chemical Structure| 5896-17-3

A125047 [5896-17-3]

2-(Benzyloxy)benzaldehyde

Similarity: 0.66

Related Parent Nucleus of
[ 13417-49-7 ]

Pyrans

Chemical Structure| 105772-14-3

A145911 [105772-14-3]

Methyl 3,6-dihydro-2H-pyran-4-carboxylate

Similarity: 0.76

Chemical Structure| 98166-23-5

A185070 [98166-23-5]

2H-Pyran-3(6H)-one

Similarity: 0.69

Chemical Structure| 6018-41-3

A381504 [6018-41-3]

Methyl 2-oxo-2H-pyran-5-carboxylate

Similarity: 0.53

Chemical Structure| 500-05-0

A437681 [500-05-0]

2-Oxo-2H-pyran-5-carboxylic acid

Similarity: 0.51